Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,919 | -$11,380 | -$5,812 | -$8,061 |
| Dep. & Amort. | $79 | $95 | $89 | $103 |
| Deferred Tax | $0 | -$214 | -$124 | -$1,371 |
| Stock-Based Comp. | $198 | $214 | $124 | $1,371 |
| Change in WC | $1,526 | $2,871 | -$2,207 | $757 |
| Other Non-Cash | -$1,193 | $263 | $124 | $1,366 |
| Operating Cash Flow | -$10,116 | -$8,151 | -$7,805 | -$5,834 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$29 | -$4 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$4 | -$29 | -$4 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $11,108 | $0 | $22,587 | $8,500 |
| Stock Repurch. | $0 | $0 | -$1,485 | -$614 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$89 | -$85 | -$79 | -$82 |
| Financing Cash Flow | $11,019 | -$85 | $21,022 | $7,803 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $899 | -$8,266 | $13,213 | $1,961 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,967 | $19,233 | $6,020 | $4,059 |
| End Cash | $11,867 | $10,967 | $19,233 | $6,020 |
| Free Cash Flow | -$10,119 | -$8,181 | -$7,809 | -$5,843 |